Yondelis trabectedin: Interim Phase II data

Interim data from the open-label, Italian Phase II ATREUS trial showed that 7 of 17 evaluable patients with biphasic/sarcomatoid MPM who received 1.3

Read the full 233 word article

How to gain access

Continue reading with a
two-week free trial.